Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States (Q40816596)

24 September 2017

title

Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States (English)

1 reference

24 September 2017

1 reference

1 reference

Candida

1 reference

4

Jones RN

1 reference

24 September 2017

1

Pfaller MA

1 reference

24 September 2017

Messer SA

2

1 reference

24 September 2017

Hollis RJ

3

1 reference

24 September 2017

Doern GV

5

1 reference

24 September 2017

Brandt ME

6

1 reference

24 September 2017

Hajjeh RA

7

1 reference

24 September 2017

publication date

1 April 1999

1 reference

Diagnostic Microbiology and Infectious Disease

24 September 2017

published in

1 reference

24 September 2017

volume

33

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

217-222

1 reference

The epidemiology of hematogenous candidiasis caused by different Candida species

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Thirteen-year evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathog

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Resistant candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Resistance of Candida species to fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Importance of Candida species other than C. albicans as pathogens in oncology patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

10.1016/S0732-8893(98)00160-6

Identifiers

DOI

1 reference

24 September 2017

1 reference